Gradishar WJ - Search Results

1

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy.

Gradishar WJ, Yardley DA, Layman R, Sparano JA, Chuang E, Northfelt DW, Schwartz GN, Youssoufian H, Tang S, Novosiadly R, Forest A, Nguyen TS, Cosaert J, Grebennik D, Haluska P. Gradishar WJ, et al. Clin Cancer Res. 2016 Jan 15;22(2):301-9. doi: 10.1158/1078-0432.CCR-15-0588. Epub 2015 Aug 31. Clin Cancer Res. 2016. PMID: 26324738 Free PMC article. Clinical Trial.

2

Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer.

Sparano JA, Speyer J, Gradishar WJ, Liebes L, Sridhara R, Mendoza S, Fry D, Egorin MJ. Sparano JA, et al. Among authors: gradishar wj. J Clin Oncol. 1999 Mar;17(3):880-6. doi: 10.1200/JCO.1999.17.3.880. J Clin Oncol. 1999. PMID: 10071279 Clinical Trial.

3

Effects of high dose raloxifene in selected patients with advanced breast carcinoma.

Gradishar W, Glusman J, Lu Y, Vogel C, Cohen FJ, Sledge GW Jr. Gradishar W, et al. Cancer. 2000 May 1;88(9):2047-53. doi: 10.1002/(sici)1097-0142(20000501)88:9<2047::aid-cncr10>3.0.co;2-e. Cancer. 2000. PMID: 10813716

4

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).

Gradishar WJ, Stephenson P, Glover DJ, Neuberg DS, Moore MR, Windschitl HE, Piel I, Abeloff MD. Gradishar WJ, et al. Cancer. 2001 Nov 15;92(10):2517-22. doi: 10.1002/1097-0142(20011115)92:10<2517::aid-cncr1602>3.0.co;2-z. Cancer. 2001. PMID: 11745184 Clinical Trial.

5

A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy.

Gradishar WJ, Hellmund R. Gradishar WJ, et al. Clin Breast Cancer. 2002 Jan;2(4):282-6. doi: 10.3816/cbc.2002.n.003. Clin Breast Cancer. 2002. PMID: 11899359 Review.

6

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.

Miller KD, Gradishar W, Schuchter L, Sparano JA, Cobleigh M, Robert N, Rasmussen H, Sledge GW. Miller KD, et al. Ann Oncol. 2002 Aug;13(8):1220-4. doi: 10.1093/annonc/mdf199. Ann Oncol. 2002. PMID: 12181245 Free article. Clinical Trial.

7

Progress in systemic adjuvant therapy of early-stage breast cancer.

Gradishar WJ, O'Regan RM. Gradishar WJ, et al. Int J Clin Oncol. 2003 Aug;8(4):239-47. doi: 10.1007/s10147-003-0338-4. Int J Clin Oncol. 2003. PMID: 12955580 Review.

8

Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.

Tedesco KL, Thor AD, Johnson DH, Shyr Y, Blum KA, Goldstein LJ, Gradishar WJ, Nicholson BP, Merkel DE, Murrey D, Edgerton S, Sledge GW Jr. Tedesco KL, et al. Among authors: gradishar wj. J Clin Oncol. 2004 Mar 15;22(6):1071-7. doi: 10.1200/JCO.2004.10.046. J Clin Oncol. 2004. PMID: 15020608 Clinical Trial.

9

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study.

Gradishar WJ, Meza LA, Amin B, Samid D, Hill T, Chen YM, Lower EE, Marcom PK. Gradishar WJ, et al. J Clin Oncol. 2004 Jun 15;22(12):2321-7. doi: 10.1200/JCO.2004.12.128. J Clin Oncol. 2004. PMID: 15197193 Clinical Trial.

10

Implications of first-line adjuvant treatment with aromatase inhibitors in recurrent metastatic breast cancer.

Sokolowicz LE, Gradishar WJ. Sokolowicz LE, et al. Among authors: gradishar wj. Clin Breast Cancer. 2004 Sep;5 Suppl 1:S24-30. doi: 10.3816/cbc.2004.s.011. Clin Breast Cancer. 2004. PMID: 15347436 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters